Howard M Belmont

New York University School Of Medicine

$36,152

Attributed

$36,152

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $15.4K · FY2005–08

$20K$15K$10K$5K$0

'05

'06

'07

'08

Funding mix

By agency

NIH$36,152 · 4

By mechanism

M01$36,152 · 4

Top collaborators

No co-investigators on record.

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Atorvastatin”

Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$35,563,545
Bradley G Hammill · Duke University$15,773,864
Karen P Alexander · Duke University$9,111,406
Issam A Awad · University Of Colorado Denver$5,441,282
Mark A Creager · Dartmouth-Hitchcock Clinic$4,548,381
Cecilia M Shikuma · University Of Hawaii At Manoa$4,467,508

Research focus

AtorvastatinHuman SubjectCell Adhesion MoleculesBone NecrosisNecrosisBlood LipidAtherosclerosisAnimal ModelAccidentsCompartment SyndromesClinical TrialsBlood VesselsBone And BonesBone MarrowAnti-Inflammatory AgentsComputer Retrieval Of Information On Scientific Projects DatabaseAvascular Necrosis Of BoneAnti-InflammatoryBaseCholesterolCholesterol BiosynthesisBiological MarkersBuffaloesAdrenal Cortex Hormones

Grant awards (5)

CLINICAL TRIAL: LIPITOR TO PREVENT AVASCULAR NECROSIS IN SYSTEMIC LUPUS ERYTHEMA$812

M01 · FY2008 · RR · contact PI

LIPITOR TO PREVENT AVASCULAR NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS$1,184

M01 · FY2007 · RR · contact PI

LIPITOR TO PREVENT AVASCULAR NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS$15,431

M01 · FY2006 · RR · contact PI

LIPITOR TO PREVENT AVASCULAR NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS$9,071

M01 · FY2005 · RR

Lipitor to Prevent Avascular Necrosis in Systemic Lupus Erythematosus$9,654

M01 · FY2004 · RR